p16 mutation spectrum in the premalignant condition Barrett's esophagus.

Mutation, promoter hypermethylation and loss of heterozygosity involving the tumor suppressor gene p16 (CDKN2a/INK4a) have been detected in a wide variety of human cancers, but much less is known concerning the frequency and spectrum of p16 mutations in premalignant conditions.We have determined the...

Full description

Bibliographic Details
Main Authors: Thomas G Paulson, Patricia C Galipeau, Lianjun Xu, Heather D Kissel, Xiaohong Li, Patricia L Blount, Carissa A Sanchez, Robert D Odze, Brian J Reid
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2585012?pdf=render
_version_ 1818361452920045568
author Thomas G Paulson
Patricia C Galipeau
Lianjun Xu
Heather D Kissel
Xiaohong Li
Patricia L Blount
Carissa A Sanchez
Robert D Odze
Brian J Reid
author_facet Thomas G Paulson
Patricia C Galipeau
Lianjun Xu
Heather D Kissel
Xiaohong Li
Patricia L Blount
Carissa A Sanchez
Robert D Odze
Brian J Reid
author_sort Thomas G Paulson
collection DOAJ
description Mutation, promoter hypermethylation and loss of heterozygosity involving the tumor suppressor gene p16 (CDKN2a/INK4a) have been detected in a wide variety of human cancers, but much less is known concerning the frequency and spectrum of p16 mutations in premalignant conditions.We have determined the p16 mutation spectrum for a cohort of 304 patients with Barrett's esophagus, a premalignant condition that predisposes to the development of esophageal adenocarcinoma. Forty seven mutations were detected by sequencing of p16 exon 2 in 44 BE patients (14.5%) with a mutation spectrum consistent with that caused by oxidative damage and chronic inflammation. The percentage of patients with p16 mutations increased with increasing histologic grade. In addition, samples from 3 out of 19 patients (15.8%) who underwent esophagectomy were found to have mutations.The results of this study suggest the environment of the esophagus in BE patients can both generate and select for clones with p16 mutations.
first_indexed 2024-12-13T21:16:55Z
format Article
id doaj.art-9e0c2d76ae5f4a5e8e82b5de1c6d00d9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T21:16:55Z
publishDate 2008-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9e0c2d76ae5f4a5e8e82b5de1c6d00d92022-12-21T23:31:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032008-01-01311e380910.1371/journal.pone.0003809p16 mutation spectrum in the premalignant condition Barrett's esophagus.Thomas G PaulsonPatricia C GalipeauLianjun XuHeather D KisselXiaohong LiPatricia L BlountCarissa A SanchezRobert D OdzeBrian J ReidMutation, promoter hypermethylation and loss of heterozygosity involving the tumor suppressor gene p16 (CDKN2a/INK4a) have been detected in a wide variety of human cancers, but much less is known concerning the frequency and spectrum of p16 mutations in premalignant conditions.We have determined the p16 mutation spectrum for a cohort of 304 patients with Barrett's esophagus, a premalignant condition that predisposes to the development of esophageal adenocarcinoma. Forty seven mutations were detected by sequencing of p16 exon 2 in 44 BE patients (14.5%) with a mutation spectrum consistent with that caused by oxidative damage and chronic inflammation. The percentage of patients with p16 mutations increased with increasing histologic grade. In addition, samples from 3 out of 19 patients (15.8%) who underwent esophagectomy were found to have mutations.The results of this study suggest the environment of the esophagus in BE patients can both generate and select for clones with p16 mutations.http://europepmc.org/articles/PMC2585012?pdf=render
spellingShingle Thomas G Paulson
Patricia C Galipeau
Lianjun Xu
Heather D Kissel
Xiaohong Li
Patricia L Blount
Carissa A Sanchez
Robert D Odze
Brian J Reid
p16 mutation spectrum in the premalignant condition Barrett's esophagus.
PLoS ONE
title p16 mutation spectrum in the premalignant condition Barrett's esophagus.
title_full p16 mutation spectrum in the premalignant condition Barrett's esophagus.
title_fullStr p16 mutation spectrum in the premalignant condition Barrett's esophagus.
title_full_unstemmed p16 mutation spectrum in the premalignant condition Barrett's esophagus.
title_short p16 mutation spectrum in the premalignant condition Barrett's esophagus.
title_sort p16 mutation spectrum in the premalignant condition barrett s esophagus
url http://europepmc.org/articles/PMC2585012?pdf=render
work_keys_str_mv AT thomasgpaulson p16mutationspectruminthepremalignantconditionbarrettsesophagus
AT patriciacgalipeau p16mutationspectruminthepremalignantconditionbarrettsesophagus
AT lianjunxu p16mutationspectruminthepremalignantconditionbarrettsesophagus
AT heatherdkissel p16mutationspectruminthepremalignantconditionbarrettsesophagus
AT xiaohongli p16mutationspectruminthepremalignantconditionbarrettsesophagus
AT patricialblount p16mutationspectruminthepremalignantconditionbarrettsesophagus
AT carissaasanchez p16mutationspectruminthepremalignantconditionbarrettsesophagus
AT robertdodze p16mutationspectruminthepremalignantconditionbarrettsesophagus
AT brianjreid p16mutationspectruminthepremalignantconditionbarrettsesophagus